Page last updated: 2024-11-07

androsterone and 2019 Novel Coronavirus Disease

androsterone has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Sezer, S1
Bal, C1
Kalem, AK1
Kayaaslan, B1
Eser, F1
Hasanoglu, İ1
Akıncı, E1
Güner, R1
Erel, Ö1
Yılmaz, G1
Al-Ruweidi, MKAA1
Ali, FH1
Shurbaji, S1
Popelka, A1
Yalcin, HC1

Other Studies

2 other studies available for androsterone and 2019 Novel Coronavirus Disease

ArticleYear
COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity.
    Endocrine, 2022, Volume: 78, Issue:2

    Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Aldosterone; Androstenedione; Androstero

2022
Dexamethasone and transdehydroandrosterone significantly reduce pulmonary epithelial cell injuries associated with mechanical ventilation.
    Journal of applied physiology (Bethesda, Md. : 1985), 2021, 04-01, Volume: 130, Issue:4

    Topics: Androsterone; Animals; Cell Death; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Cytoskeleton;

2021